Suchergebnisse - "Exemestane"

PubPharm (251)

1

Towards clinical adherence monitoring of oral endocrine breast cancer therapies by LC-HRMS-method development, validation, comparison of four sample matrices, and proof of concept

enthalten in: Analytical and bioanalytical chemistry | 2024

von Jacobs, C. | Radosa, J. | Wagmann, L. | +8

2

Simultaneous quantification of four hormone therapy drugs by LC-MS/MS : Clinical applications in breast cancer patients

enthalten in: Journal of pharmaceutical and biomedical analysis | 2024

von Mansour, B. | Ngo, C. | Schlemmer, D. | +9

3

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy : Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer

enthalten in: Annals of surgical oncology | 2023

von Hunt, K. | Suman, V. | Wingate, H. | +6

4

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients

enthalten in: The Journal of clinical endocrinology and metabolism | 2022

von Bertelsen, B. | Viste, K. | Helland, T. | +8

5

Differential biological effects of aromatase inhibitors : Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells

enthalten in: Molecular and cellular endocrinology | 2021

von Augusto, T. | Amaral, C. | Almeida, C. | +2

6

Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer

enthalten in: Clinical pharmacology and therapeutics | 2021

von Cairns, J. | Kalari, K. | Ingle, J. | +10

7

Exemestane induced cholestatic liver injury - A case report

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2021

von Fritzsche, D. | Indorf, A. | Miske, A. | +1

8

Breast Cancer Risk-Reducing Medications

enthalten in: JAMA | 2020

von Graham, D. | DiNome, M. | Ganz, P.

9

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer : study protocol of a randomized controlled trial

enthalten in: BMC cancer | 2020

von Wang, C. | Lin, Y. | Zhou, Y. | +10

10

A prospective study of bone loss in early stage postmenopausal breast cancer treated with aromatase inhibitors

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2020

von Sun, J. | Wang, Q. | Wang, L. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]